Unfortunately, the product MP0040A is not optimized for mycoplasma detection as per the Guideline for Mycoplasma NAT outlined in chapter 2.6.7 of the European Pharmacopeia in terms of specificity, sensitivity/detection limit, and robustness.
MP0040A
LookOut® Mycoplasma qPCR Detection Kit
Synonym(s):
Quantiative PCR mycoplasma detection kit
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
UNSPSC Code:
12352207
EC Number:
200-664-3
NACRES:
NA.75
Pricing and availability is not currently available.
usage
sufficient for 25 reactions
Quality Level
quality
Not suitable for clinical diagnostic use.
packaging
pkg of 1 kit
storage condition
dry at room temperature
technique(s)
PCR: suitable
application(s)
detection
microbiology
storage temp.
2-8°C
General description
The LookOut Mycoplasma PCR Detection Kit utilizes the polymerase chain reaction (PCR), which is established as the method of choice for highest sensitivity in the detection of Mycoplasma and Acholeplasma contamination in cell cultures and other cell culture derived biologicals.
The primer/probe system detects the highly conserved 23S rRNA operon coding region of the mycoplasma genome. The kit is highly specific and does not detect eukaryotic DNA. The detection spectrum includes most mycoplasma species identified as cell culture contaminants (see Table 2 in the technical bulletin). The kit contains the nucleotide dUTP instead of dTTP and is, therefore, suitable for UNG pretreatment.
This kit already contains Taq polymerase in the Mycoplasma Mix.
The primer/probe system detects the highly conserved 23S rRNA operon coding region of the mycoplasma genome. The kit is highly specific and does not detect eukaryotic DNA. The detection spectrum includes most mycoplasma species identified as cell culture contaminants (see Table 2 in the technical bulletin). The kit contains the nucleotide dUTP instead of dTTP and is, therefore, suitable for UNG pretreatment.
This kit already contains Taq polymerase in the Mycoplasma Mix.
Application
qPCR Probe Kit for high quality and reliable quantitative detection of mycoplasma DNA in research, industrial application and product testing. Usable for direct testing of cell cultures and biologicals in combination with cell culture enrichment.
Legal Information
LookOut is a registered trademark of Merck KGaA, Darmstadt, Germany
1 of 1
This Item | |||
|---|---|---|---|
| technique(s) PCR: suitable | technique(s) PCR: suitable | technique(s) PCR: suitable | technique(s) PCR: suitable |
| packaging pkg of 1 kit | packaging pkg of 1 kit | packaging - | packaging - |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C |
| storage condition dry at room temperature | storage condition protect from light | storage condition - | storage condition - |
| quality Not suitable for clinical diagnostic use. | quality - | quality - | quality - |
| usage sufficient for 25 reactions | usage kit sufficient for 5 mL mycoplasma elimination | usage sufficient for 10 amplifications, sufficient for 10 extractions, sufficient for 10 reactions | usage sufficient for 100 amplifications, sufficient for 100 extractions, sufficient for 100 reactions |
Storage Class
10 - Combustible liquids
flash_point_f
188.6 °F
flash_point_c
87 °C
wgk
WGK 3
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Roxane Verdikt et al.
EBioMedicine, 79, 103985-103985 (2022-04-17)
The multiplicity, heterogeneity, and dynamic nature of human immunodeficiency virus type-1 (HIV-1) latency mechanisms are reflected in the current lack of functional cure for HIV-1. Accordingly, all classes of latency-reversing agents (LRAs) have been reported to present variable ex vivo
Global Trade Item Number
| SKU | GTIN |
|---|---|
| MP0040A-1KT | 04061834066842 |
-
Is this product optimized for mycoplasma detection according to the Guideline for Mycoplasma NAT outlined in chapter 2.6.7 of the European Pharmacopeia in terms of specificity, sensitivity/detection limit, and robustness?
1 answer-
Helpful?
-